{"nct_id":"NCT03061812","title":"Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)","status":"COMPLETED","status_verified_date":"2021-02","start_date":"2017-04-11","start_date_type":"ACTUAL","primary_completion_date":"2020-02-12","primary_completion_date_type":"ACTUAL","completion_date":"2020-02-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}